|
Gender (male vs. female)
|
0,281
|
0,67
|
0,32–1,39
| | | |
|
Age (years) (<54 vs. ≥55)
|
0,001
|
8,92
|
3,63–21,92
|
0,002
|
5,92
|
1,95–17,96
|
|
Disease duration (years) (<5 vs. ≥5)
|
0,421
|
1,31
|
0,68–2,53
| | | |
|
T stadium (T1 and T2 vs. T3 and T4)
|
0,001
|
4,47
|
2,03–9,82
|
0,002
|
4,31
|
1,67–11,09
|
|
N stadium (N0 and Nx vs. N1a and N1b)
|
0,601
|
1,46
|
0,35–6,11
| | | |
|
Tumor type (minimally vs. widely invasive)
|
0,044
|
1,96
|
1,01–3,79
| | | |
|
Tumor size (mm) (≤39 vs. >40)
|
0,004
|
4,19
|
1,57–11,19
| | | |
|
Capsular invasion (positive vs. no or minimal)
|
0,38
|
1,42
|
0,65–3,11
| | | |
|
Vascular invasion (positive vs. no or minimal)
|
0,287
|
0,61
|
0,25–1,50
| | | |
|
Number of tumor focuses (one vs. multicentric)
|
0,104
|
1,84
|
0,88–3,85
| | | |
|
Affection of both lobes (yes vs. no)
|
0,004
|
2,93
|
1,4–6,12
|
0,005
|
3,29
|
1,42–7,62
|
|
Regional tumor infiltration (yes vs. no)
|
0,003
|
0,35
|
0,17–0,7
| | | |
|
Primary procedure (total thyroidectomy vs. less than total)
|
0,65
|
1,18
|
0,56–2,48
| | | |
|
Total thyroidectomy after lobectomy (yes vs. no)
|
0,19
|
0,44
|
0,12–1,53
| | | |
|
Type of procedure overall (total thyroidectomy vs. less than total)
|
0,836
|
0,92
|
0,4–2,09
| | | |
|
Reoperation due to relapse (yes vs. no)
|
0,035
|
0,407
|
0,17–0,94
|
0,016
|
0,3
|
0,11–0,79
|
|
Surgeon’s experience (years) (<10 vs. 10+)
|
0,25
|
0,66
|
0,32–1,33
| | | |
|
Radioiodine ablation (yes vs. no)
|
0,43
|
1,88
|
0,39–9,08
| | | |
|
Diabetes mellitus (yes vs. no)
|
0,3
|
0,53
|
0,16–1,77
| | | |
|
Hypertension (yes vs. no)
|
0,002
|
0,32
|
0,16–0,65
| | | |
|
Other malignancies (yes vs. no)
|
0,275
|
0,55
|
0,19–1,59
| | | |
|
Thyroglobulin (ng/mL) (<300 vs. >300)
|
0,925
|
1,11
|
0,11–10,9
| | | |
